CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting
- ByBenzinga-
European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending Merck & Co Inc (NYSE: MRK) Keytruda in melanoma...